Article
ACOG committee opinion no. 527: Personalized genomic testing for disease risk.
Obstetrics and gynecology - 1 Jun 2012
Abstract excerpt
Advances in genetic technologies have led to the identification of hundreds of single that are associated with a variety of complex diseases, including cancer, diabetes, cardiovascular disease, and Alzheimer disease. Although personalized genomic tests that provide information regarding the risk of development of multiple diseases may be important tools in the near future, their use is not recommended outside of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
